BridgeBio Pharma nets $135 mln

Palo Alto, California-based BridgeBio Pharma, a clinical-stage biopharmaceutical company, has raised $135 million in funding. Viking Global Investors and KKR led the round with participation from Perceptive Advisors, AIG, Aisling Capital, Cormorant Capital and Janus Funds.

North AmericaUSBriefs